Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
KALA BIO, Inc. - Common Stock
(NQ:
KALA
)
1.710
-0.380 (-18.18%)
Streaming Delayed Price
Updated: 2:08 PM EDT, Jun 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about KALA BIO, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Kala Bio (KALA) Q2 Loss Widens 15%
↗
August 08, 2025
Via
The Motley Fool
KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 08, 2025
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
August 06, 2025
From
KALA BIO, Inc.
Via
GlobeNewswire
This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
↗
July 11, 2025
Via
Benzinga
KALA Stock Earnings: Kala Bio Beats EPS for Q2 2024
↗
August 06, 2024
KALA stock results show that Kala Bio beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
KALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)
July 09, 2025
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)
July 07, 2025
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO to Present at Jefferies Global Healthcare Conference
May 29, 2025
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 14, 2025
From
KALA BIO, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
April 29, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
April 22, 2025
Via
Benzinga
KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
March 31, 2025
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO to Present at TD Cowen 45th Annual Health Care Conference
February 26, 2025
From
KALA BIO, Inc.
Via
GlobeNewswire
Kala Bio Stock Sinks On CEO Exit, But Retail Feels It’s An Overreaction
↗
February 12, 2025
Kala is set to report mid-stage trial data in the second quarter for KPI-012, its experimental treatment for persistent corneal epithelial defects.
Via
Stocktwits
Dow Drops More Than 400 Points After CPI Data
↗
February 12, 2025
This morning's hotter-than-expected CPI data sent the market reeling, after the annual inflation rate rose to 3% and the 12-month core inflation rate rose to 3.3%.
Via
Talk Markets
Topics
Economy
Stocks
Stocks / Equities
KALA BIO Announces Chief Executive Officer Transition
February 12, 2025
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO Announces $10,750,000 Private Placement
December 30, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference
November 27, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 12, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
August 08, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate Update
August 06, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO Announces $12,500,000 Private Placement
June 27, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO to Present at Jefferies Global Healthcare Conference
May 29, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA Stock Earnings: Kala Pharmaceuticals Misses EPS for Q1 2024
↗
May 14, 2024
KALA stock results show that Kala Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 14, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA Stock Earnings: Kala Pharmaceuticals Beats EPS for Q4 2023
↗
April 02, 2024
KALA stock results show that Kala Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 29, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
February 26, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 06, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 19, 2024
From
KALA BIO, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
